期刊
INTERNATIONAL JOURNAL OF NANOMEDICINE
卷 16, 期 -, 页码 4693-4712出版社
DOVE MEDICAL PRESS LTD
DOI: 10.2147/IJN.S314506
关键词
application strategies photodynamic therapy; immunogenic cell death; antitumor immunity; immunosuppressive tumor environment; nanomedicines
资金
- China Postdoctoral Science Foundation [2020M681902]
- Postdoctoral Foundation of Zhejiang Province [ZJ2020034]
- Fundamental Research Funds for the Central Universities [2021QNA7020]
With the rapid development of nanotechnology, photodynamic therapy is emerging as a novel non-invasive clinical treatment for specific cancers. Although induced cell death related to T cell-mediated antitumor immune responses through immunogenic cell death is promising, enhancing this immunogenic cell death for better efficacy remains a challenge.
Benefiting from the rapid development of nanotechnology, photodynamic therapy (PDT) is arising as a novel non-invasive clinical treatment for specific cancers, which exerts direct efficacy in destroying primary tumors by generating excessive cytotoxic reactive oxygen species (ROS). Notably, PDT-induced cell death is related to T cell-mediated antitumor immune responses through induction of immunogenic cell death (ICD). However, ICD elicited via PDT is not strong enough and is limited by immunosuppressive tumor micro environment (ITM). Therefore, it is necessary to improve PDT efficacy through enhancing ICD with the combination of synergistic tumor therapies. Herein, the recent progress of nanomaterials-based PDT combined with chemotherapy, photothermal therapy, radiotherapy, and immunotherapy, employing ICD-boosted treatments is reviewed. An outlook about the future application in clinics of nanomaterials-based PDT strategies is also mentioned.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据